INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Right to try laws and requirements in Oklahoma. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Have Enacted State Right to Try Laws | have state RTT laws | 63 O.S. §§ 3091.1-3091.7 (Right to Try Act)“This act shall be known and may be cited as the "Right to Try Act". Historical Data Laws 2015, HB 1074, c. 112, 1, eff. November 1, 2015.” | Link | 2026-10-09 | high |
| Enacted Right to Try Laws Before Federal Law | 2015 | Okla. Sess. Laws 2015, c. 112 (HB 1074)“Historical Data Laws 2015, HB 1074, c. 112, 1, eff. November 1, 2015.”Note: Stored 2017 is wrong; the act is 2015 session law (HB 1074, c. 112), effective Nov. 1, 2015. | Link | 2026-10-09 | high |
| Require Individualized Manufacturer Approval for RTT | Not verified | Not verified: no adequate source found in the October 2026 reviewNote: Enacted 2026 (SB 933, c. 190) but effective Nov. 1, 2026, i.e. signed but not yet in force as of 2026-10-09. § 3092.2 defines 'individualized investigational treatment' as treatments 'unique to and produced exclusively for use for an individual patient, based on the patients own genetic profile' (incl. ASOs, neoantigen vaccines). Oklahoma is not in Goldwater's Apr 2026 17-state list (enacted after). Stored note's 'patient-specific manufacturer approval' wording is inaccurate. | Link | 2026-10-09 | derived |
| Provide Manufacturer Liability Protection Under RTT | provide liability shield | 63 O.S. § 3091.6“The Right to Try Act does not create a private cause of action against a manufacturer of an investigational drug, biological product or device or against another person or entity involved in the care of an eligible patient” | Link | 2026-10-09 | high |
| Require Insurer Coverage of Investigational Treatments | do not require coverage | 63 O.S. § 3091.3(C)“C. A health insurance carrier may, but is not required to, provide coverage for the cost of an investigational drug, biological product or device.” | Link | 2026-10-09 | high |
View full Oklahoma profile (all layers) · Report an error on this page